Peer-reviewedCC BY-NC-ND 4.0Annals of Translational Medicine
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial
- 1Department of Obstetrics and Gynecology, Baylor College of Medicine, Division of Maternal Fetal Medicine, Texas Children’s Hospital, Houston, TX, USA
Related
- The First Open Fetal Surgery for Myelomeningocele Repair in a Bicornuate Uterus With Anterior Placenta in Central America: A Case Report From Nicaragua
- The peace and operational psychology debates on counterterrorism: Unanswered questions, lessons learned, and implications for future practice
- Matrigel scaffold, alone or with human placenta-derived mesenchymal stromal cells, improves histological repair of murine excisional wounds
- To Tap or Not to Tap? A Still Unanswered Question for Lumbar Puncture and Treatment Strategies in Asymptomatic Pediatric Papilledema: A Narrative Review
- A Rare Constellation of Omphalocele, Myelomeningocele, and Encephalocele in a Neonate Born to a Mother With Type 2 Diabetes Mellitus: A Case Report
BibTeX
@article{alhaddad2026placentaderived,
title = {{Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial}},
author = {Sara Al-Haddad and Jessian L. Munoz},
journal = {Annals of Translational Medicine},
year = {2026},
month = oct,
doi = {10.21037/atm-2026-0115},
url = {https://doi.org/10.21037/atm-2026-0115},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial
AU - Sara Al-Haddad
AU - Jessian L. Munoz
PY - 2026
DA - 2026/10/16
JO - Annals of Translational Medicine
DO - 10.21037/atm-2026-0115
UR - https://doi.org/10.21037/atm-2026-0115
SN - 2305-5839
SN - 2305-5847
ER -